Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Bear Stearns Health Innoventures L.P
investment firm
About
Bear Stearns Health Innoventures Management, L.L.C. is a venture capital firm specializing in early and mid stage investments.
- New York,New York,United States
Details
- Industries
- Venture Capital
- Operating Status
- Active
- Investor Type
- Venture Capital
Investments
Number of Investments
Number of Lead Investments
10
9
Bear Stearns Health Innoventures L.P has made 10 investments. Their most recent investment was on
Oct 21, 2006, when Tolerx raised $61M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Oct 21, 2006
Tolerx
|
Series D | $61M | Biotechnology | Yes |
|
Jul 18, 2005
Affymax
|
Series D | $60M | Biopharma | Yes |
|
Mar 29, 2005
Tolerx
|
Series D | $31M | Biotechnology | Yes |
|
Oct 12, 2004
PharmAthene
|
Series B | $50M | Biotechnology | Yes |
|
Aug 7, 2004
AGY Therapeutics
|
Series C | $9M | Biopharma | — |
Employee Profiles
Number of Employee Profiles
1
Bear Stearns Health Innoventures L.P has 1 current employee profiles, including
Executive Elizabeth Adkins Czerepak
Executive
Exits
Bear Stearns Health Innoventures L.P has had 6 exits. Bear Stearns Health Innoventures L.P most notable exits include Affymax , Raven Biotechnologies
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Jun 6, 2013 | Affymax | IPO | Biopharma | Detail |
| Jul 17, 2008 | Raven Biotechnologies | M&A | Biotechnology | Detail |
| Oct 22, 2006 | Corus Pharma | M&A | Biotechnology | Detail |
| Apr 1, 2006 | Entelos | IPO | Biotechnology | Detail |
| Oct 14, 2005 | PharmAthene | M&A | Biotechnology | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
